Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118726 · ClinicalTrials.gov registry record
Evaluation of Immediate Postpartum LARC Implementation Programs
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 21
- Enrollment target
NCT03118726 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 21 participants.
The verdict
NCT03118726 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study will engage hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs. All hospitals in New Mexico interested in implementing immediate postpartum LARC programs will be eligible to participate in the NPMC program evaluation. The study will evaluate the components of this implementation program at several New Mexico hospitals using a stepped wedge design,with components being introduced to each hospital one at a time
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2019-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118726
The ClinicalTrials.gov registry entry for NCT03118726 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03118726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118726 about?
NCT03118726 is a clinical study titled "Evaluation of Immediate Postpartum LARC Implementation Programs". This study will engage hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs. All hospitals in New Mexico interested in implementing immediate postpartum LARC programs will be eligible to participate in...
What is the current status of trial NCT03118726?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2017-04-13. Estimated completion is 2019-05-31.
Who is sponsoring clinical trial NCT03118726?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.